Allopregnanolone - La Jolla Pharmaceutical

Drug Profile

Allopregnanolone - La Jolla Pharmaceutical

Alternative Names: LJPC-0712; Niemann-Pick type C disease (NP-C) therapy - La Jolla Pharmaceutical; Pregnanolone - La Jolla Pharmaceutical

Latest Information Update: 18 Jul 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator La Jolla Pharmaceutical Company
  • Class Anxiolytics; General anaesthetics; Hypnosedatives; Pregnanes; Small molecules
  • Mechanism of Action GABA A receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Niemann-Pick disease type C
  • New Molecular Entity No

Highest Development Phases

  • Research Niemann-Pick disease type C

Most Recent Events

  • 17 Jul 2013 Early research in Niemann-Pick disease type C in USA (unspecified route)
  • 17 Jul 2013 Allopregnanolone - La Jolla Pharmaceutical (LJPC 0712) receives orphan drug status for Niemann-Pick disease type C in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top